Developing a new class of engineered live bacterial therapeutics to treat human diseases.
Saved in:
| Title: | Developing a new class of engineered live bacterial therapeutics to treat human diseases. |
|---|---|
| Authors: | Charbonneau MR; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Isabella VM; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Li N; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Kurtz CB; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA. caroline@synlogictx.com. |
| Source: | Nature communications [Nat Commun] 2020 Apr 08; Vol. 11 (1), pp. 1738. Date of Electronic Publication: 2020 Apr 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32269218 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Developing a new class of engineered live bacterial therapeutics to treat human diseases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Charbonneau+MR%22">Charbonneau MR</searchLink>; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Isabella+VM%22">Isabella VM</searchLink>; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Li+N%22">Li N</searchLink>; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Kurtz+CB%22">Kurtz CB</searchLink>; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA. caroline@synlogictx.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2020 Apr 08; Vol. 11 (1), pp. 1738. <i>Date of Electronic Publication: </i>2020 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32269218 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-020-15508-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1738 Titles: – TitleFull: Developing a new class of engineered live bacterial therapeutics to treat human diseases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Charbonneau MR – PersonEntity: Name: NameFull: Isabella VM – PersonEntity: Name: NameFull: Li N – PersonEntity: Name: NameFull: Kurtz CB IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 04 Text: 2020 Apr 08 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |